by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersBioDrive, Inc.

All Warning Letters

BioDrive, Inc.

Warning LetterOpen

BioDrive, Inc., 325 Hudson Street, 4th Floor New York , NY 10013 United States, (b)(6), (b)(7)(C)Issued Aug 24, 2026Human Foods Program

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateAug 24, 2026

Product TypeDietary Supplements

StatusOpen

Letter Details

Firm: BioDrive, Inc.
Location: BioDrive, Inc., 325 Hudson Street, 4th Floor New York , NY 10013 United States, (b)(6), (b)(7)(C)
FEI Number: N/A
Country: United States
Issue Date: August 24, 2026
Issuing Office: Human Foods Program
Product Type: Dietary Supplements
Status: Open

Subject

Dietary Supplement/Adulterated

BioDrive, Inc. FDA Warning Letter, August 24, 2026